<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:OVID (USA) Also Trade In: Germany

Ovid Therapeutics Inc $ 2.18 -0.05 (-2.24%)

Volume:
242,462
Avg Vol (1m):
488,357
Market Cap $:
87.10 Mil
Enterprise Value $:
39.74 Mil
P/E (TTM):
0.00
P/B:
1.87
Warning! GuruFocus has detected 1 Severe warning sign with OVID. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

6.6/10
Current Vs Industry Vs History
Cash-To-Debt No Debt
N/A
Interest Coverage No Debt
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.07
DISTRESS
GREY
SAFE

Profitability

2/10
Current Vs Industry Vs History
ROE % -104.36
ROA % -88.39
ROC (Joel Greenblatt) % -81083.08
3-Year EBITDA Growth Rate -47.2
N/A
3-Year EPS without NRI Growth Rate -46.5
N/A

Ratios

Current Vs Industry Vs History
PB Ratio 1.87
EV-to-EBIT -0.8
N/A
EV-to-EBITDA -0.8
N/A
Current Ratio 5.84
Quick Ratio 5.84

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.9
N/A

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 1.86
Earnings Yield (Greenblatt) % -145.18